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Abstract 
Objective: To explore the impact of the Mindfulness Based Stress Reduction (MBSR) 
program on pain severity and endocrine, physical, and psychological functioning in patients 
with chronic low back pain (CLBP). 
Methods: A total of 28 participants were enrolled in the study between January and June 
2014; 17 participants were sequentially sampled for a 8-week MBSR program, and 11 were 
placed on a waitlist control group. Pain severity, quality of life (QOL), global psychological 
functioning, and depression were assessed at baseline, at the end of treatment, and 4–5 
months post-treatment for both groups. Morning and evening salivary cortisol was assessed 
at multiple time points in participants in the MBSR group. 
Results: In comparison with baseline, evening cortisol release showed a significant increase 
post-treatment. Significant differences between groups were found in pain severity. 
Medium-to-large effect sizes were found for between-group differences in both pain 
severity and QOL.  
Conclusions: The cortisol increase in the MBSR group is a promising finding, in the 
context of CLBP hypocortisolism. Data show that the effects of the MBSR treatment may 
take time to surface. However, due to small sample size, decisive interpretation of findings 
are limited. Nevertheless, the MBSR program may show promise for CLBP and should be 
an avenue for further investigation through larger clinical trials within health care systems. 
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Introduction 
Back pain is considered to be the most frequently experienced ailment after the common 
cold, with a lifetime prevalence of 60–80% reported in cross-sectional studies from 
developed countries, and a prevalence of chronic low back pain (CLBP), i.e., pain that lasts 
for 3 months or longer, of about 10%.1 Chronic pain induces a state of disability, with dire 
economic, social and psychological consequences. Pain strongly impacts on the immune 
system and delays healing in physical trauma and surgery, leading to an increase in 
mortality2 with an incidence of 15–25%. 
Pain is often the only symptom of the vast majority of spinal disorders.3,4 As 
suggested5,6, there is no correlation between pathological findings and back pain symptoms. 
For this reason, if CLBP is ascribed only to organic causes7,8, it has a poor prognosis 
because of a low rate of resolution even with treatment.9 Psychological factors such as 
anxiety and depression seem to be more predictive of pain and disability with CLBP.10 
These factors can be viewed as expressions of dysfunctional emotional processing in 
general, and suppression of emotions in particular.11 
Mindfulness Based Stress Reduction (MBSR) was originally developed in a 
behavioural medicine setting for patients with chronic pain and stress-related complaints, 
and pain has been a key topic of research on MBSR from the beginning.12-15 Several trials 
have assessed the effect of MBSR on patients with heterogeneous chronic pain conditions, 
generally reporting positive results, with significant reductions in pain intensity maintained 
regardless of the length of assessment period.16-19 Despite this encouraging trend, recent 
reviews specific to CLBP found only inconclusive evidence of the short-term 
improvements in pain intensity and disability, even if limited evidence that MBSR can 
improve pain acceptance was acknowledged.20,21 
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When studying pain reduction with the use of MBSR, it is important to rely on bio-
markers as well as patient-reported outcomes. Cortisol is an accepted stress-related bio-
marker because anomalous levels of the hormone are found in pathologies associated with 
stress-related symptoms (anxiety, depression, negative affect), and it is known for long-
term damaging effects as a result of chronic stress.22 It is hypothesized that the 
hypothalamic-pituitary-adrenal axis (HPAA) may play a predominant role in the 
association between psychological variables and chronic pain, including CLBP.23 In fact, 
stressful experiences can alter pain thresholds by producing either stress-induced analgesia 
or hyperalgesia.24,25 HPAA activity has been found to be attenuated in chronic pain, but 
elevated in depression and hypercortisolism. Consequently, some authors have argued that 
hypocortisolism in patients with chronic pain may be due to prolonged periods of stress and 
excessive glucocorticoid release, which may lead to hyporeactivity of HPAA.26-28 However, 
literature on the relationship between chronic pain and cortisol has yielded conflicting 
results.29 The relationship of HPAA with pain is complex, especially since it has been 
found to exert a paradoxical effect on pain. The same substances are able to promote 
analgesia as well as hyperalgesia, depending on the site and mode of application. 
Based on these findings, the aim of our study was to explore the impact of the 
Mindfulness Based Stress Reduction (MBSR) program on chronic low back pain (CLBP), 
as well as on endocrine (cortisol hormone), physical, and psychological functioning. Our 
expectation is that the MBSR program may produce an amelioration of the clinical 
condition of people suffering from CLBP. 
 
Methods 
This study was conducted at the Department of Pain Management of the Hospital Santa 
Croce & Carle, Cuneo, Italy. The study was approved by the Hospital ethics committee and 
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was conducted in accordance with the Declaration of Helsinki and its later amendments. All 
participants gave their written informed consent prior to their inclusion in the study. 
 
Participants 
Participants were recruited between January and June 2014. Inclusion criteria were as 
follows: 1) CLBP for at least three months; 2) aetiology of the pain had to be: a) lumbago; 
b) sciatica due to displacement of intervertebral disc, neuralgia, neuritis, radiculitis due to 
displacement or rupture of the lumbar intervertebral disc; c) lumbosacral spondylosis 
without myelopathy; or d) fibromyalgia; 3) age between 20 and 65; and 4) willingness to 
participate in the study. Exclusion criteria were: 1) non-Italian speaking; 2) currently 
receiving psychiatric treatment; and 3) the presence of cancer, infections, vertebral collapse 
due to trauma or osteoporosis, visceral related pain, and rheumatisms. 
 If a patient met all inclusion criteria for the study, the doctor introduced the study at 
the end of the physician’s office visit as a complementary treatment, and the patient was 
then referred to the psychologists for further screening. 
Of 37 initially identified potential participants, one was a non-Italian speaker, two 
had scheduling conflicts with the time and date of the course sessions, and six were no 
longer interested after initial identification, leaving a final sample of 28 (15 women, 
average age = 48.14, SD = 11.09, median = 47). Of these, 17 were recruited before the 
beginning of the course and so were selected for the intervention group; the remaining 11 
were put onto the control waitlist. Age (p = 0.47), sex (p = 0.48), and education (p = 0.28) 
of the intervention and control groups were not significantly different (see Table 1).  
 At the beginning of the study all patients were undertaking ‘treatment as usual’, that 
means a complex array of different analgesic drugs which were different for each 
participant (see Table 1 for details). The chronic condition of these people rendered them 
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largely resistant to these treatments. This is the main reason for introducing the MBSR 
program at the Department of Pain Management. All participants were taking part to a 
MBSR program for the first time. Furthermore, none had had any previous experience with 
any kind of meditation and/or yoga practices. 
 
__________________________ 
Insert Table 1 about here 
__________________________ 
 
Procedures 
After obtaining consent, eligible participants were administered baseline study measures 
and trained for saliva sampling. The sequential sampling process began in January 2014 
and all participants who were referred after March 2014 were put into the control waitlist. 
The course was organized into 8 weekly sessions of 2 hours, included homework 
assignments, and, during the second-to-last weekend, a 7-hr session. All the techniques 
provided by the program were taught during the course, mainly: the body-scan meditation, 
sitting and walking meditation, yoga exercises, and relational mindfulness. Briefly, in 
body-scan meditation, patients were instructed to concentrate their attention on specific 
parts of their body, to find whatever feelings could be felt from that body part. Once a part 
was examined this way, attention was moved to another adjacent part, and so on, until the 
whole body was examined. In sitting meditation, patients were instructed to sit and 
concentrate their attention on the sensations present in their nostrils as they breathed in and 
out. This practice was then enriched by increasing the scope of attention to the body, seen 
as a whole, to the sounds and, finally, to the thoughts that came and left the patient’s mind 
at that time. In walking meditation, patients were asked to pay attention to what their body 
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did as they walked along. In yoga exercises, the patients were directed to extend both their 
arms and legs and intentionally direct these movements as they gradually. In relational 
mindfulness practices, the patients were asked to have a brief conversation with one another 
and direct their heightened awareness to what was happening in the relation space that had 
just been created. At the end of each session, the instructor gave reading materials for 
further study and homework assignments which usually required the patients to meditate 
for around 40 minutes a day with the aid of guided meditation which was recorded and 
made available on CDs or through web links. After the course was completed, both the 
intervention and the control group were administered post-intervention measurements, with 
follow-up by telephone at 4–5 months. 
For the entire duration of treatment, and during follow-up, both the intervention and 
control groups underwent ‘treatment as usual’, including pharmacological, surgical, and 
psychological (cognitive-behavioural) interventions. 
 
Measures 
Participants were administered the following measurements at baseline, at completion of 
the course and 4–5 months after the end of the course: 
 
1.  Cortisol hormone levels were measured in the intervention group only using saliva 
samples collected using the Salivette® Cortisol test tube (Sarstedt, Numbrecht, 
Germany, REF 51.1534.500) at 08:00 hrs, and at 23:00 hrs, and analysed through the 
electro-chemiluminescence immunoassay ‘ECLIA’ Cobas e 411 analyser (Hitachi-
Roche Diagnostics Division USA).  
2. Pain severity was measured in both groups through the Numeric Rating Scale (NRS) 
for pain, a continuous scale from 0 (‘no pain at all’) to 100 (‘my pain is as bad as it 
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could possibly be’). NRS can be administered verbally, is psychometrically valid and 
reliable, and preferable to other scales when evaluating pain for research purposes.30 
3. Quality of life (QOL) was measured in both groups with the SF-36 Health Status 
Inventory, validated for the Italian population.31 It reports two summary scores 
(physical and mental health) and eight individual scores. The physical health summary 
scale describes the general physical functioning, physical pain, and overall health of a 
patient; the mental health summary scale describes his or her social and emotional 
functioning, vitality, and the frequency of experiences related to negative affect, such 
as anxiety and depression, as well as sensations of psychological wellbeing. Good 
internal consistency and reliability of the SF-36 Health Status Inventory for the Italian 
population has been reported.31 
4. Depression was measured in both groups through the Beck Depression Inventory 
(BDI-II), a widely used 21-item multiple-choice self-report inventory of depression 
symptoms.32 Higher scores indicate more depression-related symptoms, and cut-off 
scores are available for differentiating different levels of depression severity. 
5. Compliance with the MBSR program and feedback on the general experience of 
CLBP were measured by semi-structured interviews created ad hoc. For what 
concerns compliance, the questions assessed how many sessions the participant 
attended and how many minutes of meditation were practiced during the program and 
a month since its conclusion. It also assessed whether participants reported any 
difficulties associated with the course and the exercises. For what concerns feedback 
on the general experience of CLBP, questions asked were the same at baseline and 
after treatment, as follows: a) How do you describe your lower back pain? b) When 
you feel pain in your back, what are your most common emotions, or thoughts, if any? 
c) How do you live with your lower back pain in your relationship with other people, 
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in the workplace, and in everyday life? d) What do you think of the Mindfulness 
treatment? e) How would you describe yourself as a person? f) How do you see your 
future in 5–10 years’ time? 
6. Follow-up by telephone at 4–5 months measured pain severity, QOL, and the duration 
and quality of the meditation practice. 
 
Statistical analyses 
Welch's t-tests, and paired t-tests were used to compare groups before and after treatment. 
All variables were tested for normality with the Shapiro-Wilk normality test. Cohen’s d was 
used to calculate the effect size difference between the intervention and control groups. 
Finally, an intention-to-treat analysis was employed for this study, using the Last-
Observation-Carried-Forward method. All analyses were computed using the R ‘Spring 
Dance’ version 3.1.0 program. A p value of <0.05 was considered to be significant. 
 
Results  
Retention and Engagement 
A total of 8 participants completed the meditation program and another 5 participated in at 
least 4 lessons. Four participants dropped out after 2 or 3 sessions. All participants—
excluding those who dropped after 2–3 sessions–reported having done a median of 20 
minutes of meditation-related practices per day during the course and a median of 10 
minutes 4–5 months post-treatment. Of the control group, 2 patients dropped out 4–5 
months after the end of treatment.  
Dropout rates can be ascribed to the following main factors: a) all participants in the 
intervention group were undergoing a period of worsening chronic pain, since they were 
visiting the Department of Pain Management for pain relief, and the management of such a 
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group was particularly difficult where feelings of anger and sadness were intense; b) little 
flexibility was available with the offered course, time-wise, and as such scheduling 
conflicts made participation hard for employed participants, even if notes of attendance 
were available to present at the workplace; c) most participants were willing to ‘try 
anything’ in order to get rid of their pain, but some couldn’t understand how meditation, a 
‘mental thing’, could produce benefits for pain perceived as a ‘physical thing’. At some 
level, therefore, there was prejudice about the practice, which is still new in Italy.  
 
Cortisol levels 
Cortisol measurements (Figure 1) show baseline (T0) and post-treatment (T1) intervention 
group participant cortisol levels, in µg/dL, at around 08:00 hrs (morning; M) and 23:00 hrs 
(evening; E). One participant was excluded from analysis because of sample timing issues. 
While no significant difference between baseline and after treatment was found in the 
morning, paired t(15) = 1.84, p = 0.08, a significant difference was observed in the evening 
cortisol between baseline and post-treatment, paired t(15) = 3.18, p = 0.006. However, no 
significant correlation was found between cortisol levels and the difference in pain intensity 
at baseline and after treatment. Cortisol levels obtained in a healthy subject population in 
Cuneo hospital at 08:00 and 23:00 average < 0.9µg/dL and < 0.3µg/dL, respectively (per 
the Cuneo Hospital Endocrine Department records). These data seem to suggest that no 
abnormalities, such as hypercortisolism, can be observed in the patients studied. In the 
MBSR group, post-treatment evening cortisol demonstrated an increase from baseline, 
although levels remained within the range of normal levels reported in the Cuneo 
population. However, all other cortisol measurements (at both baseline and during 
treatment) were lower in the MBSR group than that in the Cuneo general population, M-
T0: t(15) = 8.86, p < 0.0001; E-T0: t(15) = 6.09, p < 0.0001; M-T1: t(15) = 7.7, p < 0.0001. 
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__________________________ 
Insert Figure 1 about here 
__________________________ 
 
Pain severity 
Figure 2 shows NRS medians at baseline (T0), after treatment (T1) and at 4–5 months after 
treatment (T2) for both the intervention and control groups. A significant difference was 
observed between the intervention and control distributions, Welch two-sample t(22) = 
2.69, p = 0.01. The observed effect size was large (Cohen’s d = 1.03) at T2. 
 
__________________________ 
Insert Figure 2 about here 
__________________________ 
 
Quality of Life  
Summary scale results of the SF-36 Health Status Inventory are presented in Figure 3 and 
4. 
 
__________________________ 
Insert Figure 3 and 4 about here 
__________________________ 
 
The bar charts present the medians of the summary scales provided in the SF-36 
Health Status Inventory for both physical and mental wellbeing. A significant difference 
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was observed between intervention group T0 and T2 scores on both scales, Physical Health 
Summary scale paired t(16) = 3.71, p < 0.001, and Mental Health Summary scale paired 
t(16) = 3.75, p < 0.001. Comparisons between the intervention and control groups’ scores 
indicated that these patients, despite an observed increase from baseline, report a level of 
QOL well below the average for the Italian population of 53.3 for the Physical scale, t(16) 
= 5.36, p < 0.001, while no significant difference was found for the Mental scale between 
the general population average of 49.3 and participant scores, t(16) = 0.9, p = 0.37. No 
baseline difference was found between the intervention and control groups on the Physical 
scale, t(25.1) = 1.4, p = 0.15, nor on the Mental scale, t 19.5) = 1.8, p = 0.7. 
 
Depression 
No significant difference was observed in depression between the intervention (average = 
8.41, median = 9, SD = 5.91) and control (average = 6.82, median = 4, SD = 6.16) groups, 
Welch’s two-sample t(20.8) = 0.67, p = 0.5. The effect size was negligible (d = 0.26). 
 
Semi-structured interviews 
Semi-structured interview recording sessions lasted an average of 13.87 minutes (SD = 
4.92) per participant at baseline and post-treatment, for a total of 720 minutes of interviews 
across all participants. Approximately 72% of participants judged the program positively, 
with a minority (23%) reporting that they would attend the course again, given the chance. 
Nearly 17% had mixed feelings or had no opinion to offer, while the remainder (11%) were 
critical and found it a negative experience. Approximately 71% reported continuing to 
practice 4–5 months following the end of the program; of these, 33% said that they used the 
body scan most often, another 33% the formal sitting meditation, 25% the walking 
meditation, and the last 9% used a mix of mindful eating and simple present moment 
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concentration in a variety of situations. Regarding the meditation practice, 41% said they 
found it relaxing, 23% reported less pain, and 17% said it increased their wellbeing. 
 
Discussion 
In the present study of MBSR in patients with CLBP, both an evening cortisol increase and 
a reported amelioration of chronic pain were observed post-treatment. 
 Lower cortisol levels have been found in chronic pain patients as well as in some 
stress-related disorders, such as fatigue syndrome, chronic pelvic pain, and 
fibromyalgia.23,33-38 Hypocortisolism in patients with chronic pain may be due to prolonged 
periods of stress and excessive glucocorticoid release, leading to hyporeactivity of the 
HPAA; therefore, this process is believed to be causally involved in pain chronicity.26-28 
Although this finding was expected, the literature on chronic pain and basal stress 
hormones has yielded conflicting results,29,39-40 and complex confounding factors in 
salivary cortisol sampling may diminish explanatory power.41 Moreover, steroid drugs 
taken during the sampling period may account for some of the results obtained.23 Other 
confounding factors, such as depression, may explain the increase in basal cortisol levels;29 
however, no significant differences in depression were observed at either baseline or post-
treatment. Additionally, it is important to note that due to small sample size, these results 
cannot be generalized. Consequently, we conclude that, barring the above-mentioned 
cautions, these data suggest convergence of the intervention group towards more normative 
levels of glucocorticoid release. Since comparison with the control group is not possible, 
we cannot determine to what degree the MBSR treatment impacted the results observed. 
This is a limit of the study and in the future it should be clarified.  
 With regard to the chronic pain levels of the MBSR group, the results of this study 
seem to indicate an amelioration of the clinical condition, measured both directly through 
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assessment of pain levels and indirectly through the increased bodily functionality reflected 
by the QOL scales. Observed effect sizes were medium to large for the intervention group 
as compared with the control group, but the low rate of completion of the program and the 
dropout rate of the control group make these and other results difficult to interpret; 
therefore, it is not possible to draw definitive conclusions from the data presented herein. 
Anecdotally, some participants’ semi-structured interview statements seem particularly 
revealing of this state of affairs, in particular regarding pain: 
Said a participant: ‘I had greater expectations about the pain relief the meditation would 
bring. The pain is acute, it is strong, but now I feel less afraid of it. It is as if it was free no 
more, as if it was contained into something, like a gelatine container.’ 
Another participant said: ‘I can do today less than I used to do before, but now it is a little 
better; I can coexist with this pain with more awareness, I allow myself to do what I can.’ 
 
From these interviews, the decoupling of the emotional and sensory components of 
pain can be seen at work. Other studies are consistent with these findings.21,39,42-46 
Meditation, of which MBSR provides an introduction, takes time to produce effects,21,47-48 
In fact, we observed that effect sizes at the end of treatment were small, while there was a 
larger increase at 4–5 months follow-up. 
It is worth noting that, rather than addressing pain as an issue to be confronted and 
resolved head-on, the approach of Mindfulness is directed towards the acceptance of one’s 
entire present experience, which includes, among other things, unwanted experiences 
including pain, unpleasant emotions and thoughts. In this way the aim is not to reduce pain, 
but the patient’s response to it. However, it is also interesting to note that most participants 
stated that meditation was useful just for relaxation, pain reduction, and wellbeing 
purposes, while it is recognized that meditation’s primary objective is to build awareness of 
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one’s life in the present, moment by moment, as well as acceptance, while relaxation and 
other benefits are viewed as collateral effects other than the final goal of the technique.49 
Furthermore, it is worth noting that since yoga has been reported to ameliorate both 
dysfunction and disability in CLBP patients, it may have a crucial effect on pain reduction 
within the MBSR program, since the only randomized control trial that has reported 
favourable effects of MBSR on functional disability also included yoga.50 Further research, 
as Cramer et al21 noted, should include dismantling studies that separately evaluate the 
effects of different components of MBSR such as mindful meditation and yoga. 
The results observed can be explained in terms of the placebo effect. It is well 
known that the placebo response can affect mood, endocrine functions, and pain perception, 
among other things.51 Ethical standards require that patients receive the best treatment 
available; therefore, it was not possible to withhold treatment in the control group which 
underwent ‘treatment as usual’, which, in turn, was difficult to standardize. Additionally, 
patient-reported outcomes, patient’s expectations about the benefits of the treatment, and 
the quality of the relationship with the MBSR instructor, may account for increased placebo 
responses, with implications for both the endocrine and psychological outcomes. On the 
other hand, a placebo response should also be observed in the control group if this were the 
case, which was undergoing standard pharmacological treatment, invasive surgical 
techniques, and psycho-educational (cognitive-behavioural) support during the same period 
of the intervention group. Moreover, it should be noted that no significant group differences 
in pain perception and only small-to-medium effect sizes were observed immediately post-
treatment. It could be argued that the placebo effect should have been observed directly 
after the end of the treatment rather than 4–5 months later. That said, it is hard to discern 
what effects may be ascribed to effective treatment(s), placebo, or their interaction at this 
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stage. Therefore, the aim of future studies should be to minimize the placebo response or 
optimize treatment-placebo differences.  
 
Conclusion 
The use of the MBSR program for adults with CLBP revealed medium-to-large 
improvements in the intervention group as compared to the control group at 4–5 months 
post-treatment on measures of pain severity and physical and psychological functioning. 
Increases in evening cortisol release after treatment, although within normative levels, may 
be a positive sign, given that hypocortisolism has been found in many studies with CLBP 
subjects. Furthermore, data seem to suggest that the treatment exerts greater effects over 
time. Although this study has some limitations and the results cannot be generalized, the 
use of the MBSR program for CLBP shows promise and could present an avenue for 
further investigation with larger clinical trials within the context of health care systems. 
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